# Filing Detail

Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-13-005463
Filing Date
2013-09-30
Accepted
2013-09-30 16:55:26
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REGISTRATION STATEMENT | fs12013_actiniumpharma.htm | S-1 | 3795090
2 | TRANSACTION MANAGEMENT AGREEMENT | fs12013ex10xxxi_actinium.htm | EX-10.31 | 109340
3 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | fs12013ex23i_actiniumpharma.htm | EX-23.1 | 3607
10 |  | img001.jpg | GRAPHIC | 8012
| Complete submission text file | 0001213900-13-005463.txt |  | 11986300

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 |  | fil-20130630.xml | EX-101.INS | 1576926
5 |  | fil-20130630.xsd | EX-101.SCH | 85613
6 |  | fil-20130630_cal.xml | EX-101.CAL | 42447
7 |  | fil-20130630_def.xml | EX-101.DEF | 282223
8 |  | fil-20130630_lab.xml | EX-101.LAB | 606750
9 |  | fil-20130630_pre.xml | EX-101.PRE | 417145

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-191468 | Film No.: 131123900
SIC: 6770 Blank Checks